PENUMBRA INC (PEN) Fundamental Analysis & Valuation

NYSE:PEN • US70975L1070

Current stock price

329.77 USD
+0.25 (+0.08%)
At close:
329.77 USD
0 (0%)
After Hours:

This PEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PEN Profitability Analysis

1.1 Basic Checks

  • In the past year PEN was profitable.
  • In the past year PEN had a positive cash flow from operations.
  • PEN had positive earnings in 4 of the past 5 years.
  • Of the past 5 years PEN 4 years had a positive operating cash flow.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • The Return On Assets of PEN (9.73%) is better than 90.43% of its industry peers.
  • The Return On Equity of PEN (12.45%) is better than 87.77% of its industry peers.
  • PEN has a better Return On Invested Capital (8.85%) than 86.70% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PEN is below the industry average of 9.40%.
  • The last Return On Invested Capital (8.85%) for PEN is above the 3 year average (6.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROIC 8.85%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • With an excellent Profit Margin value of 12.66%, PEN belongs to the best of the industry, outperforming 86.17% of the companies in the same industry.
  • PEN's Operating Margin of 13.48% is amongst the best of the industry. PEN outperforms 81.38% of its industry peers.
  • In the last couple of years the Operating Margin of PEN has grown nicely.
  • PEN's Gross Margin of 67.14% is fine compared to the rest of the industry. PEN outperforms 72.87% of its industry peers.
  • In the last couple of years the Gross Margin of PEN has grown nicely.
Industry RankSector Rank
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PEN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PEN is destroying value.
  • PEN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PEN has more shares outstanding
  • Compared to 1 year ago, PEN has an improved debt to assets ratio.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 21.42 indicates that PEN is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 21.42, PEN belongs to the best of the industry, outperforming 94.68% of the companies in the same industry.
  • PEN has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
  • PEN's Debt to FCF ratio of 0.13 is amongst the best of the industry. PEN outperforms 92.55% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that PEN is not too dependend on debt financing.
  • PEN has a Debt to Equity ratio of 0.01. This is in the better half of the industry: PEN outperforms 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 21.42
ROIC/WACC0.99
WACC8.92%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • PEN has a Current Ratio of 6.64. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • PEN has a better Current ratio (6.64) than 84.04% of its industry peers.
  • PEN has a Quick Ratio of 4.29. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • PEN has a better Quick ratio (4.29) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 4.29
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PEN Growth Analysis

3.1 Past

  • PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.80%, which is quite impressive.
  • The Earnings Per Share has been growing by 84.42% on average over the past years. This is a very strong growth
  • PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.50%.
  • PEN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.16% yearly.
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.81% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.43% on average over the next years. This is quite good.
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue Next Year14.81%
Revenue Next 2Y14.26%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. PEN Valuation Analysis

4.1 Price/Earnings Ratio

  • PEN is valuated quite expensively with a Price/Earnings ratio of 85.88.
  • Based on the Price/Earnings ratio, PEN is valued a bit cheaper than the industry average as 65.96% of the companies are valued more expensively.
  • PEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.78.
  • Based on the Price/Forward Earnings ratio of 64.48, the valuation of PEN can be described as expensive.
  • PEN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 67.02% of the companies in the same industry.
  • PEN is valuated expensively when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 85.88
Fwd PE 64.48
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 65.96% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
  • PEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PEN is cheaper than 69.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 73.97
EV/EBITDA 58.29
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
  • PEN has an outstanding profitability rating, which may justify a higher PE ratio.
  • PEN's earnings are expected to grow with 28.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.59
PEG (5Y)1.02
EPS Next 2Y30.32%
EPS Next 3Y28.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PEN Dividend Analysis

5.1 Amount

  • No dividends for PEN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PEN Fundamentals: All Metrics, Ratios and Statistics

PENUMBRA INC

NYSE:PEN (4/10/2026, 8:04:00 PM)

After market: 329.77 0 (0%)

329.77

+0.25 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners95.21%
Inst Owner Change0%
Ins Owners2.96%
Ins Owner Change1.02%
Market Cap12.94B
Revenue(TTM)1.40B
Net Income(TTM)177.69M
Analysts70
Price Target375.96 (14.01%)
Short Float %5.44%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.62%
Min EPS beat(2)4.22%
Max EPS beat(2)5.02%
EPS beat(4)4
Avg EPS beat(4)9.18%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)10.88%
EPS beat(12)12
Avg EPS beat(12)25.19%
EPS beat(16)15
Avg EPS beat(16)21.43%
Revenue beat(2)2
Avg Revenue beat(2)3.54%
Min Revenue beat(2)3.05%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)2.83%
Min Revenue beat(4)1.67%
Max Revenue beat(4)4.03%
Revenue beat(8)7
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)1.44%
Revenue beat(16)12
Avg Revenue beat(16)1.32%
PT rev (1m)2.73%
PT rev (3m)11.11%
EPS NQ rev (1m)-1.31%
EPS NQ rev (3m)-1.77%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE 85.88
Fwd PE 64.48
P/S 9.22
P/FCF 73.97
P/OCF 54.22
P/B 9.06
P/tB 10.31
EV/EBITDA 58.29
EPS(TTM)3.84
EY1.16%
EPS(NY)5.11
Fwd EY1.55%
FCF(TTM)4.46
FCFY1.35%
OCF(TTM)6.08
OCFY1.84%
SpS35.77
BVpS36.38
TBVpS31.97
PEG (NY)2.59
PEG (5Y)1.02
Graham Number56.07
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROCE 11.52%
ROIC 8.85%
ROICexc 13.24%
ROICexgc 15.72%
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
FCFM 12.46%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
ROICexc(3y)8.66%
ROICexc(5y)5.61%
ROICexgc(3y)10.48%
ROICexgc(5y)6.87%
ROCE(3y)8.11%
ROCE(5y)5.29%
ROICexgc growth 3Y198.14%
ROICexgc growth 5YN/A
ROICexc growth 3Y208.33%
ROICexc growth 5YN/A
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.1
Cap/Depr 364.77%
Cap/Sales 4.54%
Interest Coverage 250
Cash Conversion 115.45%
Profit Quality 98.45%
Current Ratio 6.64
Quick Ratio 4.29
Altman-Z 21.42
F-Score7
WACC8.92%
ROIC/WACC0.99
Cap/Depr(3y)169.98%
Cap/Depr(5y)143.68%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.57%
Profit Quality(3y)413.32%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%
Revenue Next Year14.81%
Revenue Next 2Y14.26%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%
EBIT growth 1Y58.26%
EBIT growth 3Y214.22%
EBIT growth 5YN/A
EBIT Next Year67.7%
EBIT Next 3Y32.58%
EBIT Next 5Y26.71%
FCF growth 1Y18.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.66%
OCF growth 3YN/A
OCF growth 5YN/A

PENUMBRA INC / PEN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PEN.


What is the valuation status for PEN stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


How profitable is PENUMBRA INC (PEN) stock?

PENUMBRA INC (PEN) has a profitability rating of 8 / 10.


What is the valuation of PENUMBRA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 85.88 and the Price/Book (PB) ratio is 9.06.


Can you provide the financial health for PEN stock?

The financial health rating of PENUMBRA INC (PEN) is 8 / 10.